Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 16 min ago
PreprintAll rights reservedbioRxiv

A non-retinoid triazolopyrimidine RBP4 antagonist for the treatment of Stargardt disease

  • K. A. Rinderspacher
  • A. Varadi
  • B. Racz
  • A. S. Wasmuth
  • S.-X. Deng
  • P. Weber
  • D. W. Landry
  • P. R. Bernstein
  • K. Petrukhin1
  1. 1Columbia University Irving Medical Center
Read full textPDFDOICite

Related

  1. SPONTANEOUS RELEASE OF AN EPIRETINAL MEMBRANE IN AN ADULT PATIENT WITH STARGARDT DISEASE-A CASE REPORT
    Aliénor Vienne-Jumeau, Raphael Atia, Isabelle Audo +2
    RETINAL Cases & Brief ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMedical imaging & radiologyHAL
  2. The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression
    Mark D. Kvarta, Mai Watanabe, Satoshi Ozaki +10
    Journal of Clinical PsychopharmacologyPeer-reviewedLicence not statedFull textPharmacology & toxicologyPMC
  3. Quantitative Fundus Autofluorescence in Geographic Atrophy Secondary to AMD: Comparison With Stargardt Disease, PRPH2-Associated Retinal Dystrophies, and Healthy Controls
    Maximilian Pawloff, Marlene Hollaus, Luca Schwarzenbacher +5
    Investigative Ophthalmology & Visual SciencePeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  4. CO044 | QUALITY AND SAFETY OF VITAMIN K ANTAGONIST TREATMENT IN PEDIATRIC PATIENTS: A RETROSPECTIVE CLINICAL AUDIT FROM A SINGLE CENTER
    Chiara Ambaglio
    Bleeding, Thrombosis and Vascular BiologyPeer-reviewedCC BY-NCFull textCardiovascular medicineDOAJ
  5. CO043 | LONG TERM TREATMENT WITH VITAMIN K ANTAGONIST IN PEDIATRIC PATIENTS WITH PROSTHETIC HEART VALVE: THE BERGAMO EXPERIENCE
    Chiara Ambaglio
    Bleeding, Thrombosis and Vascular BiologyPeer-reviewedCC BY-NCFull textCardiovascular medicineDOAJ

Cite

BibTeXRIS
BibTeX
@misc{rinderspacher2026nonretinoid,
  title = {{A non-retinoid triazolopyrimidine RBP4 antagonist for the treatment of Stargardt disease}},
  author = {K. A. Rinderspacher and A. Varadi and B. Racz and A. S. Wasmuth and S.-X. Deng and P. Weber and D. W. Landry and P. R. Bernstein and K. Petrukhin},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.14.751502},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.14.751502v1},
}
RIS
TY  - UNPB
TI  - A non-retinoid triazolopyrimidine RBP4 antagonist for the treatment of Stargardt disease
AU  - K. A. Rinderspacher
AU  - A. Varadi
AU  - B. Racz
AU  - A. S. Wasmuth
AU  - S.-X. Deng
AU  - P. Weber
AU  - D. W. Landry
AU  - P. R. Bernstein
AU  - K. Petrukhin
PY  - 2026
DA  - 2026/09/14
PB  - bioRxiv
DO  - 10.64898/2026.09.14.751502
UR  - https://www.biorxiv.org/content/10.64898/2026.09.14.751502v1
ER  -